Stockscreener 앱 받기
28.74
0.88%
-0.15
전일 마감가:
$28.89
열려 있는:
$28.75
하루 거래량:
11,926
Relative Volume:
0.01
시가총액:
$1.66B
수익:
$868.45M
순이익/손실:
$158.69M
주가수익비율:
10.61
EPS:
2.7087
순현금흐름:
$328.64M
1주 성능:
+3.34%
1개월 성능:
+3.71%
6개월 성능:
+8.63%
1년 성능:
-1.83%
1일 변동 폭
$28.70
$28.87
1주일 범위
$27.27
$29.50
52주 변동 폭
$25.52
$40.87
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
28.72 | 1.67B | 868.45M | 158.69M | 328.64M | 2.7087 |
VRTX
Vertex Pharmaceuticals Inc
|
438.07 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
750.36 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.85 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.72 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
309.83 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-23 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2026-02-23 | 다운그레이드 | Truist | Buy → Hold |
| 2026-02-11 | 재개 | UBS | Neutral |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
Will Harmony’s New COO and Board Reboot Change Harmony Biosciences Holdings' (HRMY) Narrative? - simplywall.st
Analyst Upgrade: Can Harmony Biosciences Holdings Inc lead its sector in growthWeekly Earnings Recap & Weekly Market Pulse Updates - baoquankhu1.vn
Harmony Biosciences appoints COO, updates board membership - MSN
Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial? - MSN
Harmony Biosciences to Present at Needham Healthcare Conference - MyChesCo
(HRMY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Can Harmony Biosciences Holdings Inc reach all time highs this yearRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Harmony Biosciences (HRMY) CCO RSUs Vest; 3,173 Shares Withheld for Taxes - Stock Titan
Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News, Quote & History - Yahoo Finance
HRMY SEC FilingsHarmony Biosciences Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Harmony Biosciences Holdings, I (HRMY) Stock forecasts - Yahoo Finance UK
Peter Anastasiou At Harmony Biosciences Hldgs Exercises Options Worth $0 - Benzinga
Harmony Biosciences (HRMY) awards 212,241 stock options to COO Anastasiou - Stock Titan
Harmony Biosciences (HRMY) director granted 17,710 stock options at $27.74 strike - Stock Titan
Harmony Biosciences (HRMY) director Troy Ignelzi files initial Form 3 - Stock Titan
Harmony Biosciences Holdings, Inc. (HRMY) stock price, news, quote and history - uk.finance.yahoo.com
Harmony Biosciences Holdings, Inc. ($HRMY) CEO 2025 Pay Revealed - Quiver Quantitative
Harmony Biosciences Holdings (HRMY) Valuation After New COO And Board Appointments - Yahoo Finance
Harmony Biosciences Appoints Peter Anastasiou as Chief Operating Officer - The Globe and Mail
[ARS] Harmony Biosciences Holdings, Inc. SEC Filing - Stock Titan
Executive pay and board elections at Harmony Biosciences (HRMY) 2026 virtual meeting - Stock Titan
A Look At Harmony Biosciences Holdings (HRMY) Valuation After Recent Share Price Weakness - Sahm
Harmony Biosciences names Peter Anastasiou as chief operating officer By Investing.com - Investing.com India
Harmony Biosciences Holdings, Inc. (HRMY) Latest Stock News & Headlines - Yahoo Finance
Harmony Biosciences Holdings, Inc. Announces Management Changes - marketscreener.com
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board - BioSpace
Harmony Biosciences names Peter Anastasiou as chief operating officer - Investing.com
Harmony Biosciences Holdings, Inc. recently announced two significant personnel changes aimed at strengthening the company’s governance and strategic leadership. - Bitget
Harmony Biosciences (HRMY) names new COO and reshapes its board - Stock Titan
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference - Investing News Network
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
자본화:
|
볼륨(24시간):